ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Enantioselective Construction of
Pyrroloindolines via Chiral Phosphoric
Acid Catalyzed Cascade Michael
AdditionÀCyclization of Tryptamines
Quan Cai, Chuan Liu, Xiao-Wei Liang, and Shu-Li You*
State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 345 Lingling Lu, Shanghai 200032, China
Received July 24, 2012
ABSTRACT
Enantioselective construction of pyrroloindolines via chiral phosphoric acid catalyzed cascade Michael additionÀcyclization of tryptamines has
been realized. With 5 mol % of chiral phosphoric acid, enantioenriched pyrroloindoline derivatives were obtained in good yields and
enantioselectivity (up to 95% yield and 83% ee) from readily available tryptamines and enones.
Alkaloids containing a pyrroloindoline unit are a very
attractive class of natural products for their structural
complexity and significant biological properties.1 The
synthesisof these pyrroloindoline derived natural products
and relevant pharmaceuticals has attracted enormous
attention.2 Biosynthetically, the pyrroloindoline units stem
from the tryptophan and tryptophan-containing peptide.2c
Due to the ready availability of the tryptamine derivatives,
catalytically asymmetric synthesis of the pyrroloindoline
compounds via a dearomatization reaction of tryptamines
is highly desirable.3
Recently, we found that, in the presence of a catalytic
amount of chiral phosphoric acid (1a, Ar = 9-phenanthryl),4
the reaction of tetrahydrocarbazole with phenyl vinyl
ketone (2a) provides the indolenine product 3 with a
17% yield and 68% ee (eq 1).5 The low yield of this
reaction is likely due to the fact that the basic imine
(1) (a) Anthoni, U.; Christophersen, C.; Nielsen, P. H. Naturally
Occurring Cyclotryptophans and Cyclotryptamines. In Alkaloids: Chem-
ical & Biological Perspectives; Pelletier, S. W., Ed.; Pergamon: Oxford,
1999; Vol. 13, pp 163À236. (b) Barrow, C. J.; Cai, P.; Snyder, J. K.;
Sedlock, D. M.; Sun, H. H.; Cooper, R. J. Org. Chem. 1993, 58, 6016. (c)
Hochlowski, J. E.; Mullally, M. M.; Spanton, S. G.; Whittern, D. N.;
Hill, P.; McAlpine, J. B. J. Antibiot. 1993, 46, 380. (d) Fukuyama, T.;
Chen, X.; Peng, G. J. Am. Chem. Soc. 1994, 116, 3127. (e) Shaw, K. T. Y.;
Utsuki, T.; Rogers, J.; Yu, Q.-S.; Sambamurti, K.; Brossi, A.; Ge,
Y.-W.; Lahiri, D. K.; Greig, N. H. Proc. Natl. Acad. Sci. U.S.A. 2001,
98, 7605. (f) Yanagihara, M.; Sasaki-Takahashi, N.; Sugahara, T.;
Yamamoto, S.; Shinomi, M.Yamashita, I.; Hayashida, M.; Yamanoha,
B.; Numata, A.; Yamori, T.; Andoh, T. Cancer Sci. 2005, 96, 816. (g)
Isham, C. R.; Tibodeau, J. D.; Jin, W.; Xu, R.; Timm, M. M.; Bible, K. C.
Blood 2007, 2579.
(3) For a review: (a) Loh, C. C. J.; Enders, D. Angew. Chem., Int. Ed.
2012, 51, 46. For selected examples: (b) Austin, J. F.; Kim, S.-G.; Sinz,
C. J.; Xiao, W.-J.; MacMillan, D. W. C. Proc. Natl. Acad. Sci. U.S.A.
2004, 101, 5482. (c) Trost, B. M.; Quancard, J. J. Am. Chem. Soc. 2006,
128, 6314. (d) Jones, S. B.; Simmons, B.; MacMillan, D.W. C. J. Am.
Chem. Soc. 2009, 131, 13606. (e) Zheng, C.; Lu, Y.; Zhang, J.; Chen, X.;
Chai, Z.; Ma, W.; Zhao, G. Chem.;Eur. J. 2010, 16, 5853. (f) Lozano,
O.; Blessley, G.; Martinez Del Campo, T.; Thompson, A. L.; Giuffredi,
G. T.; Bettati, M.; Walker, M.; Borman, R.; Gouverneur, V. Angew.
Chem., Int. Ed. 2011, 50, 8105. (g) Jones, S. B.; Simmons, B.; Mastracchio,
A.; MacMillan, D. W. C. Nature 2011, 475, 183. (h) Cera, G.;
Chiarucci, M.; Mazzanti, A.; Mancinelli, M.; Bandini, M. Org. Lett.
2012, 14, 1350. (i) Zhu, S.; MacMillan, D. W. C. J. Am. Chem. Soc.
2012, 134, 10815.
(2) For reviews: (a) Steven, A.; Overman, L. E. Angew. Chem., Int.
Ed. 2007, 46, 5488. (b) Crich, D.; Banerjee, A. Acc. Chem. Res. 2007, 40,
151. (c) Ruiz-Sanchis, P.; Savina, S. A; Albericio, F.; Alvarez, M.
ꢀ
Chem.;Eur. J. 2011, 17, 1388. (d) Zhang, D.; Song, H.; Qin, Y. Acc.
Chem. Res. 2011, 44, 447.
r
10.1021/ol302043s
XXXX American Chemical Society